SLC13A4 expression was lower in breast cancer, head and neck squamous cell carcinoma, kidney chromophobe, thyroid cancer, and higher in renal clear cell carcinoma, hepatocellular carcinoma, cholangiocarcinoma, and rectal adenocarcinoma. Here, SLC13A4 is linked to hepatocellular carcinoma.